Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vaccifar - iron (iii) hydroxide dextran - solution for injection - 200 mg/ml - iron (iii) hydroxide dextran 560 mg/ml - iron, parenteral preparations - pig

Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vaccifar - iron (iii) hydroxide dextran - solution for injection - 200 mg/ml - iron (iii) hydroxide dextran 560 mg/ml - iron, parenteral preparations - pig

Ísrael - enska - Ministry of Health

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl.; folic acid - tablets - folic acid 0.4 mg; ferrous as iron iii hydroxide polymaltose compl. 100 mg - ferrous amino acid complex - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.

Kenía - enska - Pharmacy and Poisons Board

emcure pharmaceuticals ltd t 184, midc, bhosari, pune, maharashtra 411026, - iron iii hydroxide polymaltose complex & folic… - capsule - iron (iii) hydroxide polymaltose complex… - antianemic preparations - iron preparations: iron

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).

Ísrael - enska - Ministry of Health

lapidot medical import and marketing ltd - iron sucrose - solution for injection - iron sucrose 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - ferrovin is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb (haemoglobin),serum ferritin, tsat (transferrin saturation), serum iron, etc.).

Malasía - enska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurodrug laboratories (m) sdn. bhd. - iron(iii) hydroxide polymaltose complex -

Kenía - enska - Pharmacy and Poisons Board

ajanta pharma limited ajanta house, charkop, kandivli (west) mumbai-400 - iron (iii) hydroxide polymaltose - syrup - each 5 ml contains: iron (iii) hydroxide… - saccharated iron oxide

Kenía - enska - Pharmacy and Poisons Board

indus pharma (pvt.) ltd. plots no. 26 27 64 65 66 & 67 sector-27 korangi - iron iii hydroxide polymaltose complex - syrup - each 5ml contains: iron (iii) hydroxide… - antianemic preparations - iron preparations: iron

Kenía - enska - Pharmacy and Poisons Board

emcure pharmaceuticals ltd t 184, midc, bhosari, pune, maharashtra 411026, - iron iii hydroxide polymaltose complex + folic… - tablet - iron (iii) hydroxide polymaltose complex(as… - drugs for functional gastrointestinal disorders: